Therapeutics
Eptastigmine
Quick Links
Overview
Name: Eptastigmine
Synonyms: MF 201
Therapy Type: Small Molecule (timeline)
Target Type: Cholinergic System (timeline)
Condition(s): Alzheimer's Disease
U.S. FDA Status: Alzheimer's Disease (Discontinued)
Company: Mediolanum
Approved for: None
Background
Eptastigmine is a centrally acting cholinesterase inhibitor.
Last Updated: 16 Oct 2013
References
No Available References
Further Reading
No Available Further Reading
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.